Literature DB >> 27484773

Infectious diseases and immunological responses in adult subjects with lifetime untreated, congenital GH deficiency.

Viviane C Campos1, Mônica R Barrios2, Roberto Salvatori3, Roque Pacheco de Almeida2, Enaldo V de Melo1, Ana C S Nascimento1, Amélia Ribeiro de Jesus2, Manuel H Aguiar-Oliveira1.   

Abstract

Growth hormone is important for the development and function of the immune system, but there is controversy on whether growth hormone deficiency is associated to immune disorders. A model of isolated growth hormone deficiency may clarify if the lack of growth hormone is associated with increased susceptibility to infections, or with an altered responsiveness of the immune system. We have studied the frequency of infectious diseases and the immune function in adults with congenital, untreated isolated growth hormone deficiency. In a cross-sectional study, 35 adults with isolated growth hormone deficiency due to a homozygous mutation in the growth hormone releasing hormone receptor gene and 31 controls were submitted to a clinical questionnaire, physical examination serology for tripanosomiasis, leishmaniasis, HIV, tetanus, hepatitis B and C, and serum total immunoglobulin G, M, E and A measurement. The immune response was evaluated in a subset of these subjects by skin tests and response to vaccination for hepatitis B, tetanus, and bacillus Calmette-Guérin. There was no difference between the groups in history of infectious diseases and baseline serology. Isolated growth hormone deficiency subjects had lower total IgG, but within normal range. There was no difference in the response to any of the vaccinations or in the positivity to protein Purified Derived, streptokinase or candidin. Adult untreated isolated growth hormone deficiency does not cause an increased frequency of infectious diseases, and does not alter serologic tests, but is associated with lower total IgG levels, without detectable clinical impact.

Entities:  

Keywords:  Cellular and humoral immune response; Infectious diseases; Isolated GH deficiency; Vaccines and skin tests

Mesh:

Substances:

Year:  2016        PMID: 27484773     DOI: 10.1007/s12020-016-1061-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  47 in total

1.  GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils.

Authors:  N Hattori; T Saito; T Yagyu; B H Jiang; K Kitagawa; C Inagaki
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome.

Authors:  R Salvatori; M G Serpa; G Parmigiani; A V O Britto; J L M Oliveira; C R P Oliveira; C M Prado; C T Farias; J C Almeida; T A R Vicente; M H Aguiar-Oliveira
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  Sizes of abdominal organs in adults with severe short stature due to severe, untreated, congenital GH deficiency caused by a homozygous mutation in the GHRH receptor gene.

Authors:  Carla R P Oliveira; Roberto Salvatori; Luciana M A Nóbrega; Erick O M Carvalho; Menilson Menezes; Catarine T Farias; Allan V O Britto; Rossana M C Pereira; Manuel H Aguiar-Oliveira
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-01       Impact factor: 3.478

4.  Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells.

Authors:  C J Auernhammer; C Fottner; D Engelhardt; M Bidlingmaier; C J Strasburger; M M Weber
Journal:  Horm Res       Date:  2002

5.  Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene.

Authors:  R Salvatori; C Y Hayashida; M H Aguiar-Oliveira; J A Phillips; A H Souza; R G Gondo; S P Toledo; M M Conceicão; M Prince; H G Maheshwari; G Baumann; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

6.  Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital.

Authors:  R J Thomas; G J Fletcher; H Kirupakaran; M P Chacko; S Thenmozhi; C E Eapen; G Chandy; P Abraham
Journal:  Indian J Med Microbiol       Date:  2015-02       Impact factor: 0.985

7.  Spectrum of illness in pediatric common variable immunodeficiency.

Authors:  Paul R Ogershok; Mary Beth Hogan; Jon E Welch; W Thomas Corder; Nevin W Wilson
Journal:  Ann Allergy Asthma Immunol       Date:  2006-11       Impact factor: 6.347

8.  Insulin-like growth factor I messenger RNA and protein are expressed in the human lymph node and distinctly confined to subtypes of macrophages, antigen-presenting cells, lymphocytes and endothelial cells.

Authors:  Dominique Oberlin; Christian Fellbaum; Elisabeth Eppler
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

9.  Climacteric in untreated isolated growth hormone deficiency.

Authors:  Menilson Menezes; Roberto Salvatori; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Luciana M A Nobrega; Edla A C Cruz; Marcos Menezes; Erica O Alves; Manuel H Aguiar-Oliveira
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

Review 10.  Growth hormone (GH) insensitivity due to primary GH receptor deficiency.

Authors:  R G Rosenfeld; A L Rosenbloom; J Guevara-Aguirre
Journal:  Endocr Rev       Date:  1994-06       Impact factor: 19.871

View more
  7 in total

Review 1.  Growth Hormone Deficiency: Health and Longevity.

Authors:  Manuel H Aguiar-Oliveira; Andrzej Bartke
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 2.  Targeting growth hormone function: strategies and therapeutic applications.

Authors:  Man Lu; Jack U Flanagan; Ries J Langley; Michael P Hay; Jo K Perry
Journal:  Signal Transduct Target Ther       Date:  2019-02-08

3.  Growth hormone-mediated reprogramming of macrophage transcriptome and effector functions.

Authors:  Augusto Schneider; Hillary N Wood; Sandra Geden; Catherine J Greene; Robin M Yates; Michal M Masternak; Kyle H Rohde
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

4.  Individuals with isolated congenital GH deficiency due to a GHRH receptor gene mutation appear to cope better with SARS-CoV-2 infection than controls.

Authors:  Manuela A Melo; Lysandro P Borges; Roberto Salvatori; Daniela R V Souza; Hertz T Santos-Júnior; José M de R Neto; Viviane C Campos; Aryanne A Santos; Carla R P Oliveira; Grazielly B da Invenção; Vanderlan O Batista; Igor L S Matos; Cynthia S Barros-Oliveira; Kezia A Dos Santos; Elenilde G Santos; Nicolas A A Souza; Enaldo V Melo; Pamela C Borges; Saulo E F S Santos; Brenda M de Oliveira; Alécia A Oliveira-Santos; Amélia R de Jesus; Manuel H Aguiar-Oliveira
Journal:  Endocrine       Date:  2021-04-16       Impact factor: 3.633

Review 5.  Disruption of the GHRH receptor and its impact on children and adults: The Itabaianinha syndrome.

Authors:  Manuel H Aguiar-Oliveira; Roberto Salvatori
Journal:  Rev Endocr Metab Disord       Date:  2020-09-16       Impact factor: 6.514

6.  Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae.

Authors:  Khalil Farhat; Gwennaëlle Bodart; Chantal Charlet-Renard; Christophe J Desmet; Michel Moutschen; Yves Beguin; Frédéric Baron; Pierrette Melin; Pascale Quatresooz; Anne-Simone Parent; Daniel Desmecht; Jean-Claude Sirard; Roberto Salvatori; Henri Martens; Vincent G Geenen
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

7.  Macrophages From Subjects With Isolated GH/IGF-I Deficiency Due to a GHRH Receptor Gene Mutation Are Less Prone to Infection by Leishmania amazonensis.

Authors:  Mônica R Barrios; Viviane C Campos; Nalu T A Peres; Laís L de Oliveira; Rodrigo A Cazzaniga; Márcio B Santos; Murilo B Aires; Ricardo L L Silva; Aline Barreto; Hiro Goto; Roque P Almeida; Roberto Salvatori; Manuel H Aguiar-Oliveira; Amélia M R Jesus
Journal:  Front Cell Infect Microbiol       Date:  2019-08-30       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.